Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Possible pediatric nephrotoxicity of cisplatin

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: ABDELRAHMAN, Sarah (Children's Cancer Hospital Egypt, Department of Pharmaceutical Services & Sciences)
  • Co-author(s): Sarah Mohamed Abdelrahman
    Sarah Salah
    Mahmoud Hamza
    Hala Zaki: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
    Alaa Al Haddad: Department of Pediatric Oncology & Stem Cell Transplant, Children's Cancer Hospital , Cairo, Egypt
    Helmy Moawad: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
  • Abstract:

    Background

    Risk of Cisplatin (CDDP) nephrotoxicity, increases with increased cumulative dose, bolus dosage and associated nephrotoxic drugs. Early detection & management improves patient care.

    Methods

    51 patients scheduled to receive CDDP-based chemotherapy were recruited and scored for nephrotoxic events throughout chemotherapy course, then

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses